EX-10.1



 Exhibit 10.1 
  

					
	



	  		  	 333 Allerton Ave

South San Francisco, CA 94080
  

PHONE (650) 741-0900

FAX (650) 741-0901
  

MYOKARDIA.COM


 March 26, 2018 

Mr. Taylor Harris 
 87 Wildwood Gardens 

Piedmont, CA 94611 
 Dear Taylor, 

We are pleased to offer you the position of Chief Financial Officer with MyoKardia, Inc. Your compensation will be $17,291.67, semi-monthly, which is equal to
$415,000.00 annualized, payable in accordance with the Company’s standard payroll schedule. This position will report directly to me. This is a full-time position. While you render services to the Company, you will not engage in any other
employment, consulting or other business activity (whether full-time or part-time) that would create a conflict of interest with the Company. By signing this letter, you confirm to the Company that you have no contractual commitments or other legal
obligations that would prohibit you from performing your duties for the Company. 
 Cash Compensation: This salary will be subject to adjustment
pursuant to the Company’s employee compensation policies in effect from time to time. In addition, the company has a performance-based variable cash bonus program. Subject to an acceptable level of corporate performance, the Board of Directors
may approve payment of performance bonuses after the first of next year. If bonuses are paid, your target percentage will be 40% of your salary as the basis for calculating your bonus. Your actual bonus will depend on your own and the company’s
performance for the year just completed. Bonuses will be pro-rated for partial years of service and only if you are hired prior to October 1 of the current year. 

Employee Benefits: As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits, including
401(k) Retirement and Investment Plan and also in ESPP (Employee Stock Purchase Plan) during scheduled enrollment periods. In addition, you will be entitled to 20 days of paid time off in accordance with the Company’s policy. You can also
review additional benefits information in the attached MyoKardia Employee Benefits Information Guide 2018. 
 Stock Options: Subject to the
approval of the Company’s Compensation Committee, you will be granted an option to purchase 100,000 shares of the Company’s Common Stock. The exercise price per share will be equal to the closing price of the Company’s Common
Stock as reported on NASDAQ as of April 4, 2018. The options will be subject to the terms and conditions applicable to options granted under the Company’s 2015 Stock Option and Incentive Plan (the “Plan”), as described in
the Plan and the applicable stock option agreement. You will vest in 25% of the option shares after 12 months of continuous employment, and the balance will vest in equal monthly installments over the next 36 months of continuous employment, as
described in the applicable stock option agreement. 
 Restricted Stock Units. Subject to the approval of the Company’s
Compensation Committee, you will be granted Restricted Stock Units (“RSUs”) for 15,000 shares of the Company’s Common Stock under the Plan, effective as of April 4, 2018 (such date, the “Grant Date”). You will vest
in 25% of the shares underlying the RSUs after 12 months of continuous employment from the Grant Date, and the balance will vest in equal annual installments over the next three (3) years of your continuous employment, as described in the
applicable RSU award agreement. 
 Employee Confidentiality and Assignment Agreement: You will be required, as a condition of your employment with
the Company, to sign the Company’s standard Employee Confidentiality and Assignment Agreement, a copy of which is attached. 

  
 



 









 Taylor Harris 

March 26, 2018 
  Page
 2
 
  

 Background Check: The Company may conduct a background or reference check (or both). If so, then you
agree to cooperate fully in those procedures, and this offer is subject to the Company’s approving the outcome of those checks, in the discretion of the Company. 

Employment Relationship: Employment with the Company is for no specific period of time. Your employment with the Company will be “at will,”
meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause. Any contrary representations that may have been made to you are superseded by this letter agreement. This is the full and
complete agreement between you and the Company on this term. Although your job duties, title, reporting relationship, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the
“at will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the Company (other than you). 

Change in Control Benefits: As a senior leader, you will be eligible for the benefits available to members of the Company’s senior management team
pursuant to the terms and conditions of the Company’s Change in Control Policy (as the same may be amended from time to time), a copy of which will be made available to you upon request. 

Taxes: All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable withholding and payroll taxes and
other deductions required by law. You agree that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or its Board of Directors
related to tax liabilities arising from your compensation. 
 Interpretation, Amendment and Enforcement: This letter agreement, the Employee
Confidentiality and Assignment Agreement and Exhibit A constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or
understandings (whether written, oral or implied) between you and the Company. This letter agreement may not be amended or modified, except by an express written agreement signed by both you and a duly authorized officer of the Company. The terms of
this letter agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this letter agreement or arising out of, related to, or in any way connected with, this letter agreement, your employment with the Company
or any other relationship between you and the Company will be governed by California law, excluding laws relating to conflicts or choice of law. 
 We look
forward to working with you, and hope that you will accept our offer to join the Company. You may indicate your agreement with these terms and accept this offer by signing and dating both the enclosed duplicate original of this letter agreement and
the enclosed Proprietary Information and Inventions Agreement and return these documents to the Human Resources Department to confirm your acceptance no later than March 29, 2018, as this offer, if not accepted, will expire at the close of
business on March 29, 2018. As required by law, your employment with the Company is contingent upon your providing legal proof of your identity and authorization to work in the United States. We would like your official start date to be on or
before April 4, 2018. 
 If you have any questions, please do not hesitate to contact me at 650-741-7796. 

 

	
	Very truly yours,
	
	/s/ Tassos Gianakakos
	Tassos Gianakakos
	Chief Executive Officer

  

					
	ACKNOWLEDGMENT AND ACCEPTANCE OF THE TERMS STATED ABOVE:
			
	 /s/ Taylor Harris
	 		 	                4-4-18       
             
	Taylor Harris	 		 	Agreed upon start date


  
 



 








 Attachment 

Employee Confidentiality and Assignment Agreement 
 Exhibit A -
Prior Inventions 
 Exhibit B - California Labor Code (reference)